Novo Nordisk xStock

Novo Nordisk (NVO), the Danish pharmaceutical company that supplies more of the world's insulin than any other and sells semaglutide as Ozempic and Wegovy, earning from prescription medicines sold mainly in the United States. It has worked on diabetes since 1923, and control sits with the Novo Nordisk Foundation, a charitable foundation in Copenhagen that holds the majority of the voting shares. NVOx is a tokenised tracker certificate from Backed Assets (JE) Limited, following the NVO share price on-chain.